Data integrity considerations in Pharma and Life Sciences
European Pharmaceutical Review
MARCH 12, 2024
Transparent communication with regulatory authorities ; this is key during the product development and regulatory submission process. It is advisable to address any concerns or issues related to data integrity proactively and demonstrate a commitment to resolving them in a timely and effective manner.
Let's personalize your content